Tsui DW, Berger MF. Profiling Non-Small Cell Lung Cancer: From Tumor to Blood. Clin Cancer Res. 2016 Feb 15;22(4):790-2. doi: 10.1158/1078-0432.CCR-15-2514.

Murtaza M, Dawson SJ, Pogrebniak K, Rueda OM, Provenzano E, Grant J, Chin SF, Tsui DW, Marass F, Gale D, Ali HR, Shah P, Contente-Cuomo T, Farahani H, Shumansky K, Kingsbury Z, Humphray S, Bentley D, Shah SP, Wallis M, Rosenfeld N, Caldas C. Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer. Nat Commun. 2015 Nov 4;6:8760. doi: 10.1038/ncomms9760.

K.M. Patel, D. W. Y. Tsui.  The translational potential of circulating tumour DNA in oncology. Clin Biochem. 2015 doi: 10.1016.

Hong MK, Macintyre G, Wedge DC, Van Loo P, Patel K, Lunke S, Alexandrov LB, Sloggett C, Cmero M, Marass F, Tsui D, Mangiola S, Lonie A, Naeem H, Sapre N, Phal PM, Kurganovs N, Chin X, Kerger M, Warren AY, Neal D, Gnanapragasam V, Rosenfeld N, Pedersen JS, Ryan A, Haviv I, Costello AJ, Corcoran NM, Hovens CM. Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer. Nat Commun. 2015 Apr 1;6:6605. doi: 10.1038/ncomms7605.

M. Murtaza*, S.J. Dawson*, D. W. Y. Tsui*, D. Gale, T. Forshew, A. M. Piskorz, C. Parkinson, S. F. Chin, Z. Kingsbury, A. S. Wong, F. Marass, S. Humphray, J. Hadfield, D. Bentley, T. M. Chin, J. D. Brenton, C. Caldas, N. Rosenfeld. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 2013 497 (7447), 108-112.  (*Co-first authors)

S.J. Dawson*, D. W.Y. Tsui*, M. Murtaza, H. Biggs, O. M. Rueda, S. F. Chin, M. J. Dunning, D. Gale, T. Forshew, B. Mahler-Araujo, S. Rajan, S. Humphray, J. Becq, D. Halsall, M. Wallis, D. Bentley, C. Caldas, N. Rosenfeld. Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer.  N Engl J Med. 2013 368 (13), 1199-1209. (*Co-first authors)

P.J. Voon, D.W.Y. Tsui, N. Rosenfeld, T.M. Chin. EGFR Exon 20 Insertion A763-Y764insFQEA and response to Erlotinib. Mol Cancer Ther. 2013 doi: 10.1158/1535-7163.MCT-13-0192.

T. Forshew*, M. Murtaza*, C. Parkinson*, D. Gale*, D. W. Y. Tsui*, F. Kaper, S. J. Dawson, A. M. Piskorz, M. Jimenez-Linan, D. Bentley, J. Hadfield, A. P. May, C. Caldas, J. D. Brenton, N. Rosenfeld. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci Transl Med. 2012 4,136ra68.  (*Co-first authors)

D. W. Y. Tsui, Y.M.D. Lam, W.S. Lee, T.Y. Leung, T.K. Lau, E.T. Lau, M.H.Y Tang, R. Akolekar, K.H. Nicolaides, R.W.K. Chiu, Y.M.D. Lo, S.S.C. Chim. Systematic identification of placental epigenetic signatures for the noninvasive prenatal detection of Edwards Syndrome PLoS One. 2010 5(11), e15069.

D. W. Y. Tsui, Chiu RWK, Lo YMD. Epigenetic approaches for the detection of fetal DNA in maternal plasma. Chimerism. 2010 1:1, 1-6.

D. W. Y. Tsui, K.C. Chan, S.S.C. Chim, L.W. Chan, T.Y. Leung, T.K. Lau, Y.M. Lo, R.W.K. Chiu Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre‐eclampsia Prenatal diagnosis. 2007 27(13), 1212-1218.